Kohl’s Names New CEO

WSJ Minute Briefing

Plus: Novo Nordisk’s stock slumps after its said semaglutide didn’t slow Alzheimer’s disease in two late-stage clinical trials. And former Fox News host Tucker Carlson has launched a precious-metals company. Alex Ossola hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More description

Plus: Novo Nordisk’s stock slumps after its said semaglutide didn’t slow Alzheimer’s disease in two late-stage clinical trials. And former Fox News host Tucker Carlson has launched a precious-metals company. Alex Ossola hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2025-11-24 1 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.